New bladder cancer drug tested directly in the bladder

NCT ID NCT06637423

Summary

This early-stage study is testing a new drug called Sacituzumab Tirumotecan (Sac-TMT) for people with a specific type of bladder cancer that hasn't spread into the muscle wall. The drug is delivered directly into the bladder. The main goals are to find a safe dose and see how well the body handles it, before checking if it can effectively treat the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-MUSCLE INVASIVE BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CIUSSS de l'Estrie-CHUS ( Site 0002)

    RECRUITING

    Sherbrooke, Quebec, J1H 5N4, Canada

    Contact Phone: •••-•••-••••

  • Erasmus Medisch Centrum ( Site 0032)

    RECRUITING

    Rotterdam, South Holland, 3015 GD, Netherlands

    Contact Phone: •••-•••-••••

  • Gustave Roussy ( Site 0013)

    RECRUITING

    Villejuif, Val-de-Marne, 94805, France

    Contact Phone: •••-•••-••••

  • HENRI MONDOR HOSPITAL ( Site 0011)

    RECRUITING

    Créteil, Val-de-Marne, 94010, France

    Contact Phone: •••-•••-••••

  • Hospital Universitario 12 de Octubre ( Site 0042)

    RECRUITING

    Madrid, 28041, Spain

    Contact Phone: •••-•••-••••

  • Hospital Universitario Virgen de la Victoria ( Site 0043)

    RECRUITING

    Málaga, Andalusia, 29010, Spain

    Contact Phone: •••-•••-••••

  • Hôpital Claude Huriez ( Site 0012)

    RECRUITING

    Lille, Nord, 59037, France

    Contact Phone: •••-•••-••••

  • Johns Hopkins University ( Site 0055)

    RECRUITING

    Baltimore, Maryland, 21287, United States

    Contact Phone: •••-•••-••••

  • Michael G Oefelein Clinical Trials ( Site 0053)

    RECRUITING

    Bakersfield, California, 93301, United States

    Contact Phone: •••-•••-••••

  • Moffitt Cancer Center ( Site 0057)

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact Phone: •••-•••-••••

  • Northwestern University ( Site 0051)

    RECRUITING

    Chicago, Illinois, 60611, United States

    Contact Phone: •••-•••-••••

  • Princess Margaret Cancer Centre ( Site 0003)

    RECRUITING

    Toronto, Ontario, M5G 2M9, Canada

    Contact Phone: •••-•••-••••

  • St Bartholomew s Hospital ( Site 0061)

    RECRUITING

    London, London, City of, EC1A 7BE, United Kingdom

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.